Patients help design device to stop chemo nerve damage
NCT ID NCT06873360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved 50 people with gastrointestinal cancer who had nerve pain from the chemotherapy drug oxaliplatin. Researchers interviewed patients to understand their symptoms and how the pain affected their daily life. The goal was to use this information to design a medical device that could prevent or reduce this nerve damage. The study did not test a treatment, but gathered insights to guide future device development.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Consorci Corporació Sanitària Parc Taulí
Sabadell, Barcelona, 08208, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could common food additives be friend or foe? a massive study investigates
- Can artificial intelligence think like a cancer tumor board?
- Yogurt as medicine? Butyrate-Rich formula tested for Cancer-Related constipation
- New care model aims to close cancer treatment gaps for people with mental illness
- Smartphone app aims to uncover food triggers for gut cancer survivors
- Immunotherapy may let some GI cancer patients skip the knife